248 related articles for article (PubMed ID: 16679553)
1. Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.
Kooncumchoo P; Sharma S; Porter J; Govitrapong P; Ebadi M
J Mol Neurosci; 2006; 28(2):125-41. PubMed ID: 16679553
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
Sharma SK; Ebadi M
Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.
Ebadi M; Brown-Borg H; El Refaey H; Singh BB; Garrett S; Shavali S; Sharma SK
Brain Res Mol Brain Res; 2005 Mar; 134(1):67-75. PubMed ID: 15790531
[TBL] [Abstract][Full Text] [Related]
4. Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.
Ebadi M; Sharma SK; Ghafourifar P; Brown-Borg H; El Refaey H
Methods Enzymol; 2005; 396():276-98. PubMed ID: 16291239
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Yang L; Calingasan NY; Wille EJ; Cormier K; Smith K; Ferrante RJ; Beal MF
J Neurochem; 2009 Jun; 109(5):1427-39. PubMed ID: 19476553
[TBL] [Abstract][Full Text] [Related]
6. Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease.
Ebadi M; Sharma S
Exp Biol Med (Maywood); 2006 Oct; 231(9):1576-83. PubMed ID: 17018883
[TBL] [Abstract][Full Text] [Related]
7. Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.
Sikorska M; Lanthier P; Miller H; Beyers M; Sodja C; Zurakowski B; Gangaraju S; Pandey S; Sandhu JK
Neurobiol Aging; 2014 Oct; 35(10):2329-46. PubMed ID: 24775711
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K
J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567
[TBL] [Abstract][Full Text] [Related]
9. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
10. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
Aoki E; Yano R; Yokoyama H; Kato H; Araki T
Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.
Cleren C; Yang L; Lorenzo B; Calingasan NY; Schomer A; Sireci A; Wille EJ; Beal MF
J Neurochem; 2008 Mar; 104(6):1613-21. PubMed ID: 17973981
[TBL] [Abstract][Full Text] [Related]
12. NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation.
Zhou JS; Zhu Z; Wu F; Zhou Y; Sheng R; Wu JC; Qin ZH
Acta Pharmacol Sin; 2019 Feb; 40(2):180-191. PubMed ID: 29769744
[TBL] [Abstract][Full Text] [Related]
13. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
[TBL] [Abstract][Full Text] [Related]
14. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
15. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?
Youdim MB
J Neural Transm Suppl; 2003; (65):73-88. PubMed ID: 12946050
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
17. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.
Campolo M; Casili G; Biundo F; Crupi R; Cordaro M; Cuzzocrea S; Esposito E
Antioxid Redox Signal; 2017 Sep; 27(8):453-471. PubMed ID: 28006954
[TBL] [Abstract][Full Text] [Related]
18. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Mandel S; Maor G; Youdim MB
J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of total flavonoid fraction of the Epimedium koreanum Nakai extract on dopaminergic neurons: In vivo and in vitro.
Wu L; Du ZR; Xu AL; Yan Z; Xiao HH; Wong MS; Yao XS; Chen WF
Biomed Pharmacother; 2017 Jul; 91():656-663. PubMed ID: 28494419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
